HTR2A genetic variants as risk factors for cigarette smoking at an early age and relapse to smoking cessation treatment.
G. Pérez-Rubio (Mexico, Mexico), L. López-Flores (Mexico, Mexico), S. García-Carmona (Mexico, Mexico), L. García-Gómez (Mexico, Mexico), V. Noé-Díaz (Mexico, Mexico), E. Ambrocio-Ortiz (Mexico, Mexico), K. Nava-Quiroz (Mexico, Mexico), F. Morales-González (Mexico, Mexico), A. Del Angel-Pablo (Mexico, Mexico), A. Ramírez-Venegas (Mexico, Mexico), R. Falfán-Valencia (Mexico, Mexico)
Source: International Congress 2018 – Tobacco use and cessation interventions in patients with respiratory, cardiovascular and mental health problems and other populations
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Pérez-Rubio (Mexico, Mexico), L. López-Flores (Mexico, Mexico), S. García-Carmona (Mexico, Mexico), L. García-Gómez (Mexico, Mexico), V. Noé-Díaz (Mexico, Mexico), E. Ambrocio-Ortiz (Mexico, Mexico), K. Nava-Quiroz (Mexico, Mexico), F. Morales-González (Mexico, Mexico), A. Del Angel-Pablo (Mexico, Mexico), A. Ramírez-Venegas (Mexico, Mexico), R. Falfán-Valencia (Mexico, Mexico). HTR2A genetic variants as risk factors for cigarette smoking at an early age and relapse to smoking cessation treatment.. 1241
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: